Markt geschlossen -
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
12’556 GBX | -0.27% | +3.00% | +18.45% |
07.06. | JPMorgan belässt Astrazeneca auf 'Overweight' - Ziel 13000 Pence | DP |
05.06. | ASTRAZENECA PLC : HSBC gibt eine Kauf-Bewertung ab | ZM |
ETFs investiert in AstraZeneca PLC
Name | Gewichtung | Volumen | % 1. Jan. | Investm. Rating |
---|---|---|---|---|
9,20% | 11 M€ | +0.83% | - | |
5,39% | 218 M€ | +18.70% | ||
5,17% | 21 M€ | +8.41% | - | |
4,89% | 801 M€ | +13.24% | ||
4,11% | 88 M€ | +10.37% | - | |
3,47% | 262 M€ | +13.30% | ||
2,74% | 4 M€ | -.--% | - | |
2,57% | 6 M€ | -.--% | ||
2,53% | 7 M€ | +11.44% | - | |
2,53% | 664 M€ | +9.05% | ||
1,54% | 29 M€ | +8.37% | - | |
1,51% | 2 M€ | +9.19% | - | |
1,51% | 2 M€ | -.--% | - | |
1,26% | 12 M€ | +15.09% | - | |
1,19% | 51 M€ | +8.41% | ||
1,16% | 10 M€ | -3.35% | - | |
0,97% | 7 M€ | +5.53% | - | |
0,89% | 35 M€ | +5.55% | - | |
0,86% | 276 M€ | +11.40% | - | |
0,70% | 261 M€ | -.--% | - | |
0,69% | 200 M€ | +11.72% | - | |
0,69% | 488 M€ | +14.46% | ||
0,57% | 205 M€ | -.--% | ||
0,54% | 284 M€ | -.--% | ||
0,51% | 23 M€ | -.--% | - | |
0,51% | 786 M€ | -.--% | ||
0,50% | 206 M€ | -.--% | ||
0,48% | 749 M€ | +8.64% | ||
0,43% | 288 M€ | +21.58% | ||
0,38% | 607 M€ | +0.05% | - |
Verlauf des Gewinns je Aktie
% 1. Jan. | Kap. | |
---|---|---|
+18.45% | 248 Mrd. | |
+45.82% | 765 Mrd. | |
+40.95% | 632 Mrd. | |
-6.16% | 354 Mrd. | |
+19.86% | 331 Mrd. | |
+9.32% | 299 Mrd. | |
-0.78% | 219 Mrd. | |
+11.88% | 216 Mrd. | |
+5.90% | 164 Mrd. | |
-0.73% | 162 Mrd. |
- Börse
- Aktien
- 886455 Aktie
- ETFs AstraZeneca PLC